![]() The Biggest Tech Bet in History. Plus. . . Hollywood neuters ‘Animal Farm.’ How perimenopause became big business. The Iran-backed group terrorizing Europe’s Jews. And more.
This spring or early summer, Elon Musk’s SpaceX is going to go public. (Illustration by The Free Press)
It’s Monday, May 4. This is The Front Page, your daily window into the world of The Free Press—and our take on the world at large. Today: The Iran-backed group behind attacks on Europe’s Jews. Hollywood doesn’t understand George Orwell. The quest for Viagra for women. And much more. But first: The civilizational ambition of SpaceX. But they said that about Tesla, too, didn’t they? In his lead story today, Patrick examines Musk’s gargantuan SpaceX wager, which is as much a bet on human ambition as it is on any one technology. In fact, it might just be the most audacious bet in business history. But will it pay off? That’s the question on everyone’s lips as SpaceX prepares to go public, and it’s the one at the heart of Patrick’s story. —Mark Gimein For years, big pharma often overlooked and neglected women’s health. That is changing, with billions being spent, and made, catering to female customers in new ways. The change brings promise—and peril. Today, two stories about that paradox. First: perimenopause, a term that is suddenly everywhere on the internet. From celebrity confessions by Drew Barrymore and Katherine Heigl to influencers pushing “Perimenopause Is Hot” merchandise, the hormonal transition into menopause has become a cultural touchstone. How did perimenopause wind up in the spotlight? Kara Kennedy explores how a once-taboo topic transformed into a highly marketable obsession—and why perimenopause is not the catchall explanation it’s sold as. Meanwhile, a new documentary is out addressing a different kind of hormonal question: Why isn’t there “Viagra for women”? While The Pink Pill: Sex, Drugs & Who Has Control blames medical sexism for the rocky rollout of the libido pill, Jennifer Block argues that the truth is more complicated. Read her full take on how what really brought down the “female Viagra” was weak data and worrisome side effects. |